“The CDC quietly announced last week that it was withdrawing its request to the FDA for Emergency Use Authorization (EUA) of the 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2.”

https://www.lewrockwell.com/2021/07/no_author/cdc-to-withdraw-emergency-use-authorization-for-rt-pcr-test-because-it-cannot-distinguish-between-sars-cov-2-and-the-flu/